Tetratherix Ltd (TTX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tetratherix Ltd (TTX) has a cash flow conversion efficiency ratio of -0.186x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.53 Million ≈ $-3.21 Million USD) by net assets (AU$24.37 Million ≈ $17.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TTX net assets for net asset value and shareholders' equity analysis.
Tetratherix Ltd - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Tetratherix Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Tetratherix Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tetratherix Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kerevitas Gida Sanayi ve Ticaret AS
IS:KERVT
|
0.003x |
|
COG Financial Services Ltd
AU:COG
|
0.198x |
|
Launch Two Acquisition Corp.
NASDAQ:LPBBU
|
-0.001x |
|
Grand Fortune Securities Co Ltd
TWO:6026
|
-0.003x |
|
Iberpapel Gestion SA
MC:IBG
|
0.040x |
|
Rico Auto Industries Limited
NSE:RICOAUTO
|
0.197x |
|
Melon SA
SN:MELON
|
0.064x |
|
Clarke Inc.
TO:CKI
|
0.009x |
Annual Cash Flow Conversion Efficiency for Tetratherix Ltd (2023–2025)
The table below shows the annual cash flow conversion efficiency of Tetratherix Ltd from 2023 to 2025. For the full company profile with market capitalisation and key ratios, see TTX market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$27.25 Million ≈ $19.28 Million |
AU$-2.67 Million ≈ $-1.89 Million |
-0.098x | -125.96% |
| 2024-06-30 | AU$-6.78 Million ≈ $-4.80 Million |
AU$-2.56 Million ≈ $-1.81 Million |
0.378x | +343.15% |
| 2023-06-30 | AU$-4.56 Million ≈ $-3.22 Million |
AU$-388.24K ≈ $-274.70K |
0.085x | -- |
About Tetratherix Ltd
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.